Some studies suggest that aneurysmal disease requires anti-VEGFA therapy to reduce inflammation and tissue destruction (51), whereas recent studies suggest that promoting VEGFA expression may contributed to accelerating endothelialization after stent implantation (52, 53). Here, VEGFA is linked to Vascular dilatation.